Ignite Creation Date:
2025-12-25 @ 2:47 AM
Ignite Modification Date:
2026-01-08 @ 10:37 PM
Study NCT ID:
NCT01667133
Status:
COMPLETED
Last Update Posted:
2022-06-13
First Post:
2012-08-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Ponatinib in Japanese Participants With Chronic Myeloid Leukemia (CML) and Ph+ Acute Lymphoblastic Leukemia (ALL)
Sponsor:
Ariad Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-08-31
Start Date Type:
ACTUAL
Primary Completion Date:
2018-08-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-08-02
Completion Date Type:
ACTUAL
First Submit Date:
2012-08-13
First Submit QC Date:
None
Study First Post Date:
2012-08-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-03-01
Results First Submit QC Date:
None
Results First Post Date:
2022-06-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-09
Last Update Post Date:
2022-06-13
Last Update Post Date Type:
ACTUAL